Insight Molecular Diagnostics Inc. (IMDX) at a glance

Insight Molecular Diagnostics Inc. (IMDX) is a micro-cap Healthcare company. It trades at $4.28, with a 56.7% profit margin and revenue decline of 98.5%. It does not pay a dividend. Vestovix scores it 44/100 overall. Its strongest dimension is Safety (66/100) and its weakest is Growth (12/100).

Price

$4.28

Market cap

$181.1M

P/E ratio

n/a

Dividend yield

None

Beta

n/a

52-week range

$2.33 to $8.51